Atlas Venture Fund XI, L.P. - Insider Trading & Ownership

Entity
Company
Location
400 Technology Square, 10 Th Floor, Cambridge, MA
Summary
The estimated value of insider holdings of Atlas Venture Fund XI, L.P. is at least $255M dollars as of February 28, 2024. Atlas Venture Fund XI, L.P. is the 10%+ Owner of Dyne Therapeutics, Inc. and owns shares of Dyne Therapeutics, Inc. (DYN) stock worth about $166M. Atlas Venture Fund XI, L.P. is the 10%+ Owner of Day One Biopharmaceuticals, Inc. and owns shares of Day One Biopharmaceuticals, Inc. (DAWN) stock worth about $70.2M. Atlas Venture Fund XI, L.P. is the 10%+ Owner of Ikena Oncology, Inc. and owns shares of Ikena Oncology, Inc. (IKNA) stock worth about $11.4M. Atlas Venture Fund XI, L.P. is the 10%+ Owner of Third Harmonic Bio, Inc. and owns shares of Third Harmonic Bio, Inc. (THRD) stock worth about $6.12M. Atlas Venture Fund XI, L.P. is the 10%+ Owner of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $1.76M.
All Insider Reports
All Insider Reports

Ownership of Atlas Venture Fund XI, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
DYN Dyne Therapeutics, Inc. 10%+ Owner $166M -$42.8M -20.5% Feb 26, 2024
DAWN Day One Biopharmaceuticals, Inc. 10%+ Owner $70.2M Dec 12, 2022
IKNA Ikena Oncology, Inc. 10%+ Owner $11.4M Mar 30, 2021
THRD Third Harmonic Bio, Inc. 10%+ Owner $6.12M Sep 19, 2022
XLO Xilio Therapeutics, Inc. 10%+ Owner $1.76M -$4.24K -0.24% Feb 8, 2024

Insider Transactions Reported by Atlas Venture Fund XI, L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.